Voyager Therapeutics, Inc. financial data

Symbol
VYGR on Nasdaq
Location
75 Hayden Avenue, Lexington, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574 % +41.7%
Debt-to-equity 42.5 % -46.2%
Return On Equity 3.31 % -95.2%
Return On Assets 2.33 % -94%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.5M shares +24.2%
Common Stock, Shares, Outstanding 54.5M shares +24.5%
Entity Public Float 489M USD +330%
Common Stock, Value, Issued 54K USD +22.7%
Weighted Average Number of Shares Outstanding, Basic 57.7M shares +32.6%
Weighted Average Number of Shares Outstanding, Diluted 57.7M shares +32.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 44.3M USD -77.3%
Research and Development Expense 113M USD +52%
General and Administrative Expense 37.3M USD +12.6%
Operating Income (Loss) -6.65M USD -108%
Nonoperating Income (Expense) 16.4M USD +76.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.71M USD -90%
Income Tax Expense (Benefit) 683K USD -59.3%
Net Income (Loss) Attributable to Parent 9.02M USD -90.6%
Earnings Per Share, Basic 0.16 USD/shares -93.3%
Earnings Per Share, Diluted 0.16 USD/shares -93%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.1M USD -68.8%
Marketable Securities, Current 295M USD +936%
Cash, Cash Equivalents, and Short-term Investments 371M USD +36%
Other Assets, Current 2.63M USD -37.9%
Assets, Current 382M USD +35.2%
Property, Plant and Equipment, Net 16.3M USD -5.64%
Operating Lease, Right-of-Use Asset 35.5M USD +144%
Assets 436M USD +38.2%
Accounts Payable, Current 2.61M USD +57%
Employee-related Liabilities, Current 4.76M USD +27.7%
Accrued Liabilities, Current 10.3M USD +13.4%
Contract with Customer, Liability, Current 20.5M USD -35.2%
Liabilities, Current 40.1M USD -11.6%
Contract with Customer, Liability, Noncurrent 19.5M USD -62.1%
Operating Lease, Liability, Noncurrent 40.2M USD +115%
Other Liabilities, Noncurrent 41.2M USD +109%
Liabilities 101M USD -13.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -522K USD -292%
Retained Earnings (Accumulated Deficit) -283M USD +3.09%
Stockholders' Equity Attributable to Parent 335M USD +68.5%
Liabilities and Equity 436M USD +38.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 58.8M USD -52.4%
Net Cash Provided by (Used in) Financing Activities 113M USD +260%
Net Cash Provided by (Used in) Investing Activities -96.1M USD -763%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 54.5M shares +24.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 75.6M USD -55.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 79M USD -67.9%
Deferred Tax Assets, Valuation Allowance 82.6M USD -29.6%
Deferred Tax Assets, Gross 89M USD -28.7%
Depreciation 1.2M USD +11.3%
Payments to Acquire Property, Plant, and Equipment 2.14M USD +321%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8.63M USD -91%
Property, Plant and Equipment, Gross 31.5M USD -10.1%
Operating Lease, Liability, Current 6.74M USD +124%
Deferred Tax Assets, Operating Loss Carryforwards 13.7M USD -71%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 619M USD +26%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 6.43M USD -13.4%
Share-based Payment Arrangement, Expense 13.5M USD +38.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%